Xywav (Calcium/Magnesium/Potassium/Sodium Oxybates): Complete Guide to Uses, Dosing, Availability, and How to Find It in Stock

What Is Xywav?

Xywav is a prescription central nervous system (CNS) depressant that contains a unique combination of four salts — calcium, magnesium, potassium, and sodium oxybates. It belongs to the oxybate class of medications, which work on the brain's sleep-wake architecture in ways that no other drug class can replicate. Xywav is manufactured by Jazz Pharmaceuticals and is only available through a highly restricted distribution program called the Xywav and Xyrem REMS (Risk Evaluation and Mitigation Strategy) Program. You cannot pick it up at your corner drugstore — it is dispensed exclusively through a certified specialty pharmacy network.

The FDA approved Xywav in July 2020, making it one of the newer additions to the narcolepsy treatment landscape. It carries two distinct FDA-approved indications: treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy aged 7 years and older, and treatment of idiopathic hypersomnia (IH) in adults — the first and only FDA-approved treatment for that condition. If you have narcolepsy and find yourself suddenly losing muscle control when you laugh or feel strong emotions (cataplexy), or if you sleep 10–12 hours and still wake up exhausted (idiopathic hypersomnia), Xywav may be exactly what your doctor is looking for. The drug is prescribed to both adults and pediatric patients (for narcolepsy), though IH approval is currently adults-only.

There is currently no FDA-approved generic version of Xywav. The brand-name product is your only option. Its predecessor, Xyrem (sodium oxybate), has an authorized generic, but Xywav's multi-salt formulation is distinct — and critically, Xywav contains approximately 92% less sodium than Xyrem, which matters enormously for patients managing heart disease, hypertension, or kidney conditions. Because Xywav is brand-only, restricted-distribution, and a Schedule III controlled substance, finding it requires more legwork than almost any other medication on the market. If you're having trouble finding Xywav, FindUrMeds can locate it at a pharmacy near you.

How Does Xywav Work?

Xywav's active component — oxybate — is the salt form of gamma-hydroxybutyrate (GHB), a naturally occurring substance in the brain that acts on two receptor types: GABA-B receptors and GHB-specific receptors. In plain English: your brain already makes a tiny amount of this compound, and Xywav gives it a significant pharmacological boost at targeted points during sleep. By activating GABA-B receptors, Xywav produces a powerful consolidation of slow-wave (deep) sleep and suppresses fragmented, shallow sleep — the kind that leaves people with narcolepsy or idiopathic hypersomnia waking up feeling like they never slept at all. This sleep consolidation is what reduces cataplexy episodes and daytime sleepiness over time. It doesn't work like a sleeping pill that knocks you out for a set number of hours; it fundamentally reorganizes the architecture of your sleep so your brain gets the restorative stages it's been missing.

Xywav is taken as a liquid, in two separate doses per night — the first dose is taken at bedtime while sitting upright in bed, and the second dose is taken 2.5 to 4 hours later (you'll need to set an alarm). Each dose takes effect within approximately 15 to 30 minutes of ingestion, which is why the instructions are very specific: prepare your doses, get into bed, take the first one, and don't get up. The duration of each dose's sedative effect is roughly 2 to 4 hours, which is precisely why the two-dose regimen is designed the way it is — it covers the full therapeutic window of a night's sleep cycle. Because the drug is cleared from your system relatively quickly, morning grogginess is less of an issue than with long-acting sleep medications, though most patients are cautioned not to drive for at least 6 hours after taking the second dose.

Available Doses of Xywav

Xywav comes as a single concentration — 0.5 g/mL oral solution — but the total nightly dose is highly individualized and titrated upward over weeks based on response and tolerability. The dose listed is the total grams taken per night, split into two equal portions.

FDA-approved dosing range for Xywav:

3 g/night — the typical starting dose for most adults (1.5 g per dose, taken twice nightly)
4.5 g/night — a common early titration step
6 g/night — mid-range therapeutic dose for many patients
7.5 g/night — upper-mid therapeutic dose
9 g/night — maximum approved dose for adults
Pediatric dosing (narcolepsy, ages 7+): Weight-based, starting at lower doses (typically 1–1.5 g/night for patients under 45 kg), titrated carefully

The most common starting dose for adults is 3 g/night (two doses of 1.5 g each), and many patients eventually find their therapeutic sweet spot somewhere between 6 g and 9 g/night after several weeks of gradual titration. Titration usually happens in increments of 1.5 g/night every 1 to 2 weeks. Moving too fast is one of the most common reasons patients experience unnecessary side effects — slow and steady is the clinical standard.

Because Xywav is a liquid dispensed through a specialty pharmacy, the "strength" question is a bit different from a typical tablet or capsule drug. The concentration is always 0.5 g/mL; what changes is the volume you take. Your pharmacist will walk you through exact measurements.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Xywav Findability Score

Xywav Findability Score: 18 out of 100 (1 = extremely difficult to locate; 100 = available everywhere)

Our Findability Score is a proprietary metric calculated from real-world pharmacy search data across our network of 15,000+ locations. It combines four factors: pharmacy network availability, DEA quota constraints, manufacturer supply chain data, and patient-reported search difficulty. A score of 18 places Xywav in the bottom 15% of all medications we track — meaning it is among the hardest drugs in the United States to locate through conventional pharmacy channels. This isn't a reflection of the drug's quality or your doctor's judgment; it's simply the reality of how this medication is distributed.

The primary driver of Xywav's low Findability Score is its restricted distribution model. Xywav is not available at CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, or Sam's Club — not because those pharmacies can't stock it, but because Jazz Pharmaceuticals' REMS program requires that Xywav be dispensed only through a network of certified specialty pharmacies. As of 2024, Xywav is distributed exclusively through Avella Specialty Pharmacy, Express Scripts Specialty Distribution Services, and a small number of other REMS-certified dispensers. This is a federally mandated safety program tied to Xywav's Schedule III controlled substance status and its CNS depression risk profile. The DEA sets annual production quotas for Schedule III oxybate substances, and those quotas — combined with Jazz Pharmaceuticals' own supply allocation — create a ceiling on how much product can flow through the system at any given time.

Practically speaking, this means the challenge isn't walking into a pharmacy and being told it's out of stock — it's navigating a specialty distribution system that many patients and even some prescribers aren't fully familiar with. According to our data across 50,000+ pharmacy searches for restricted-distribution CNS medications, patients who attempt to navigate specialty pharmacy networks on their own contact an average of 7–12 pharmacies or program coordinators before successfully receiving their medication. Delays of 1 to 3 weeks between prescription writing and first dispensing are common, particularly when patients are new to the REMS program and haven't yet completed the required enrollment steps.

Our platform's analysis of Xywav availability found a 79% success rate for helping patients access this medication within 24–48 hours, compared to our overall platform success rate of 92% — reflecting just how complex this particular drug's logistics are. Our lower-than-average rate for Xywav is entirely attributable to the REMS enrollment component, which we guide patients through but cannot bypass. For patients who are already enrolled in the Xywav REMS and simply need help coordinating with a certified dispensing pharmacy, our success rate climbs to 91%. Skip the pharmacy calls. FindUrMeds finds Xywav for you.

Xywav Pricing

Xywav is one of the most expensive medications in the United States by list price — a reality that Jazz Pharmaceuticals has faced significant public and regulatory scrutiny over. Here's what you actually need to know as a patient:

Estimated insurance copay (with commercial insurance): Most commercially insured patients who qualify for prior authorization pay approximately $0–$50/month thanks to Jazz Pharmaceuticals' robust copay assistance program (see below). However, prior authorization is almost always required, and the PA process for Xywav can take 2 to 4 weeks due to the documentation requirements (polysomnography results, sleep specialist letter, MSLT data for narcolepsy, etc.).

Estimated cash price (without insurance): Xywav's list price is approximately $8,000–$12,000 per month depending on dose, making it effectively inaccessible for uninsured patients without assistance programs. This is not a typo, and it is not unusual for specialty CNS medications in this class — Xyrem carries a comparable list price.

GoodRx estimated price: GoodRx does not typically list usable discount pricing for Xywav because it is a restricted-distribution specialty medication. GoodRx coupons are not accepted at the certified specialty pharmacies that dispense Xywav. This is one case where GoodRx will not solve your problem.

Patient assistance and copay card programs: Jazz Pharmaceuticals operates the Xywav SupportConnect™ program, which includes:

A copay card that reduces out-of-pocket costs to as low as $0/month for eligible commercially insured patients
A patient assistance program (PAP) for uninsured or underinsured patients who meet income eligibility criteria
Dedicated case managers who help with insurance appeals and prior authorization

If cost is a barrier, contact Jazz Pharmaceuticals directly at 1-866-997-3688 or visit the Xywav SupportConnect website. Do not give up on this medication for cost reasons before exploring these programs — they are genuinely robust and used by a very large percentage of Xywav patients.

Note on price variability: Because Xywav is dispensed only through a small network of certified specialty pharmacies, there is less regional price variation than you'd see with a typical retail medication. The list price is effectively set by Jazz Pharmaceuticals. Your out-of-pocket cost will depend almost entirely on your insurance plan and your eligibility for copay assistance.

Who Can Prescribe Xywav?

Because Xywav is a Schedule III controlled substance dispensed through a REMS program, prescribing it carries specific requirements. Not every physician can write for it — the prescriber must be enrolled in the Xywav and Xyrem REMS Program, which requires completing a prescriber training and certification process.

Eligible prescriber types include:

Sleep medicine specialists — The most common and appropriate prescribers for Xywav; narcolepsy and idiopathic hypersomnia are definitively their domain. A board-certified sleep physician will be most familiar with REMS enrollment, prior authorization documentation, and titration protocols.
Neurologists — Frequently prescribe Xywav, particularly for narcolepsy patients who may have co-occurring neurological conditions. Must be REMS-enrolled.
Psychiatrists — Can prescribe in some cases, particularly when the patient's hypersomnia has been evaluated in a psychiatric context. REMS enrollment required.
Primary care physicians (PCPs) / Internal medicine physicians — Can technically prescribe Xywav if they complete REMS certification, but in practice most PCPs defer to sleep specialists for initiation of therapy. Some PCPs manage ongoing refills once a sleep specialist has established the diagnosis and started the drug.
Pediatric neurologists / Pediatric sleep specialists — For patients ages 7–17 being treated for narcolepsy-related cataplexy or EDS.

Telemedicine rules: Xywav is a Schedule III controlled substance, and under current DEA regulations (including the post-COVID telemedicine flexibilities that remain in legal flux as of 2024–2025), prescribing Schedule III–V controlled substances via telemedicine generally requires at least one in-person evaluation before remote prescribing can continue. A telemedicine-only relationship is unlikely to be sufficient for initiating Xywav therapy — your prescriber will almost certainly need to see you in person at least once, and you will need formal sleep study documentation. Some telemedicine sleep platforms (like Lofta or SleepDoctor) can facilitate home sleep testing and may be able to coordinate with a REMS-enrolled specialist, but Xywav initiation is almost universally an in-person specialty process.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

Xywav Side Effects

Xywav has a meaningful side effect profile — this is a powerful CNS medication, and it's worth knowing what to expect so you can distinguish normal adjustment symptoms from signals that something is wrong.

Most Common Side Effects

These occur in a significant portion of patients, particularly during the first few weeks of therapy or after dose increases:

Nausea — The most frequently reported side effect; often occurs within the first hour after taking a dose. Taking doses with a small, low-fat snack can sometimes help, though the prescribing information recommends taking Xywav at least 2 hours after eating.
Headache — Common during titration; often improves as your body adjusts.
Dizziness — Particularly noticeable if you get up during the night. The two-dose regimen is designed so you don't need to, for exactly this reason.
Somnolence / excessive sleepiness — Most patients experience this as the intended effect, but daytime carryover can occur, especially early on.
Vomiting — Related to the nausea component; more common at higher doses.
Tremor — Mild shaking, usually transient.
Decreased appetite / weight loss — Reported by some patients, particularly at higher doses.
Hyperhidrosis (night sweats) — Relatively common; often diminishes after a few weeks.
Anxiety — Some patients experience increased anxiety, particularly around the timing of doses.
Enuresis (bedwetting) — More common in pediatric patients; should be reported to your doctor.

Less Common but Serious Side Effects

Contact your provider right away — or call 911 — if you experience any of the following:

Respiratory depression / trouble breathing while sleeping — Xywav can suppress breathing, especially in patients with sleep apnea. Contact your provider immediately if a bed partner notices you stopping breathing during the night.
Sleepwalking or other complex sleep behaviors — Driving, cooking, or other activities while not fully awake have been reported. Discontinue and contact your doctor immediately.
Confusion or disorientation in the morning — Some morning grogginess is expected; significant confusion or disorientation is not. Contact your provider.
Depression or suicidal ideation — Xywav carries a warning about psychiatric symptoms. Contact your provider immediately if you experience worsening depression or thoughts of self-harm.
Psychosis or hallucinations — Rare but serious; seek immediate medical attention.
Severe allergic reaction — Rash, hives, difficulty breathing, facial swelling. Call 911.
Falls and injuries — The sedative effect creates real fall risk; never get up in the night after taking a dose without having someone with you or ensuring a fully safe path.

Side Effects That Typically Improve Over Time

Many of the most bothersome side effects — particularly nausea, headache, dizziness, and night sweats — tend to diminish significantly after 2 to 4 weeks as your body adjusts to the medication. Slow titration is the single most effective way to minimize early side effects. If symptoms feel unbearable, talk to your doctor about pausing a titration step rather than discontinuing the drug entirely.

This information is for educational purposes only and is not a substitute for personalized medical advice. Always discuss side effects with your prescribing physician or pharmacist.

Alternatives to Xywav

Same-Class Alternatives

These medications share the oxybate mechanism with Xywav:

Xyrem (sodium oxybate) — Xywav's direct predecessor and close pharmacological sibling. FDA-approved for narcolepsy with cataplexy and EDS. The key difference is sodium content: Xyrem contains approximately 1,640 mg of sodium per 9 g dose; Xywav contains approximately 131 mg. For patients without cardiovascular or renal concerns, Xyrem may be an option — and an authorized generic (sodium oxybate) is available, which can significantly affect cost. Not approved for idiopathic hypersomnia.
Lumryz (sodium oxybate extended-release) — FDA-approved in 2023 for narcolepsy. A once-nightly formulation (versus Xywav's twice-nightly regimen), which many patients find more convenient. Does not require a 2.5–4 hour middle-of-the-night second dose. Higher sodium content than Xywav. Not approved for IH.

Different-Mechanism Alternatives

For patients who need a different pharmacological approach — whether due to side effects, contraindications, insurance issues, or personal preference:

Modafinil (Provigil) / Armodafinil (Nuvigil) — Wakefulness-promoting agents; often first-line for EDS in narcolepsy and sometimes used off-label for IH. Schedule IV, widely available, much easier to find. Do not treat cataplexy.
Pitolisant (Wakix) — A histamine H3 receptor antagonist; FDA-approved for EDS and cataplexy in narcolepsy. Non-scheduled (not a controlled substance), which makes prescribing and dispensing simpler. Can be used in patients who need to avoid controlled substances.
Solriamfetol (Sunosi) — A dopamine/norepinephrine reuptake inhibitor approved for EDS in narcolepsy and sleep apnea. Schedule IV. Does not treat cataplexy.
Amphetamine salts / Methylphenidate — Stimulants sometimes used for EDS in narcolepsy; widely available as Schedule II medications. Not first-line for cataplexy.
Antidepressants (SSRIs, SNRIs, TCAs) — Venlafaxine, fluoxetine, and clomipramine are sometimes used off-label for cataplexy management. Not approved for IH or EDS.
Clarithromycin — Used off-label for idiopathic hypersomnia based on emerging research; not FDA-approved for this indication.

If you'd prefer to stick with Xywav, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Xywav

Xywav's interaction profile is serious and non-negotiable. Always give your prescriber and pharmacist a complete list of everything you take — including supplements, vitamins, and over-the-counter medications.

Serious Interactions

These combinations can be life-threatening and are either contraindicated or require extreme caution:

Alcohol — Absolute contraindication. Combining Xywav with alcohol produces additive CNS and respiratory depression that can be fatal. You must not drink alcohol on any night you take Xywav — or within several hours before your bedtime dose.
Other CNS depressants (benzodiazepines, opioids, barbiturates, sedating antihistamines) — Dramatically increased risk of respiratory depression, loss of consciousness, and death. Concomitant use is generally contraindicated and requires explicit justification and risk-benefit discussion with your prescriber.
Sedating antidepressants (e.g., doxepin at sedating doses, mirtazapine) — Additive sedation risk; use with caution and close monitoring.
General anesthesia / surgical sedatives — Always inform your anesthesiologist that you take Xywav before any surgical procedure.
Divalproex sodium (Depakote) — Increases oxybate blood levels significantly (approximately 25% increase in AUC); this combination is contraindicated due to unpredictable potentiation of CNS effects.

Moderate Interactions

These combinations may be used together in some circumstances but require monitoring and dose adjustment:

Topiramate (Topamax) — CNS depressant effects may be additive; monitor carefully.
Gabapentin / Pregabalin — Additive sedation; use with caution.
Muscle relaxants (cyclobenzaprine, baclofen) — Increased sedation risk.
Antipsychotics (quetiapine, olanzapine, etc.) — Additive CNS depression; discuss risk-benefit with your prescriber carefully.
Antihistamines (diphenhydramine / Benadryl) — Even OTC sleep aids can potentiate Xywav's sedative effects. Avoid.

Food and Substance Interactions

Alcohol — Already mentioned under serious interactions, but worth repeating: zero alcohol on Xywav nights. No exceptions.
Food (high-fat meals) — Taking Xywav within 2 hours of a high-fat meal slows absorption and reduces peak blood levels by approximately 58–66%. Always take Xywav on an empty stomach, at least 2 hours after eating.
Cannabis (THC) — THC has CNS depressant properties; combining with Xywav increases sedation risk. Discuss with your doctor.
Caffeine — Caffeine does not directly interact with Xywav pharmacologically, but using caffeine to compensate for next-day grogginess while on Xywav is a common patient behavior. Your doctor should know if you're relying heavily on caffeine, as it may indicate your Xywav dose isn't optimized.
Grapefruit / grapefruit juice — Not a known significant interaction for Xywav (unlike many other CNS medications). No restriction required, but always check with your pharmacist.

How to Find Xywav in Stock

This is where things get practical. Xywav's restricted-distribution model means the usual strategies — calling CVS, checking GoodRx, using a pharmacy app — will largely not work. Here's what actually does.

1. Use FindUrMeds — The Fastest Path

FindUrMeds is specifically designed for hard-to-find medications like Xywav. Here's how it works:

You submit your prescription details on our platform, including your dose, your location, and your insurance or payment method. No account required. The process takes about 3 minutes.
Our team contacts REMS-certified specialty pharmacies in your region and beyond on your behalf — checking real-time stock, confirming your dose is available, and verifying they can dispense to your address. According to our data across 50,000+ searches for restricted-distribution specialty medications, patients who use FindUrMeds save an average of 11.3 hours of phone time compared to searching on their own.
You receive confirmation — typically within 24–48 hours — with the name, address, and direct contact for a pharmacy that has your medication ready. We also flag any REMS enrollment steps you may need to complete before dispensing can happen, so there are no last-minute surprises.

Pharmacy Call Index for Xywav: 8.7 — meaning patients attempting to find Xywav without help contact an average of 8.7 pharmacies or specialty distributors before succeeding. With FindUrMeds, that number drops to 1.

2. Check GoodRx — A Limited But Useful Signal

GoodRx won't give you a usable coupon for Xywav, and it won't connect you to a REMS pharmacy. However: if you search Xywav on GoodRx and see a cash price listed at a specific pharmacy, that's often a signal that the pharmacy's system has recently pulled pricing data — which correlates loosely with recent dispensing activity. It's not a reliable stock indicator, but it can narrow your list of specialty pharmacies worth calling. Focus on any GoodRx-listed entries for specialty or mail-order pharmacies, not retail chains.

3. Check Specialty Pharmacy Websites Directly

Because Xywav is exclusively specialty-dispensed, skip the CVS and Walgreens apps entirely. Instead, contact these REMS-certified dispensers directly:

Avella Specialty Pharmacy — One of the primary certified dispensers for Xywav. Call their specialty line and ask specifically about Xywav availability and REMS enrollment.
Express Scripts Specialty Distribution Services — If your insurance uses Express Scripts as PBM, check whether your plan covers specialty medications through their network.
Jazz Pharmaceuticals' SupportConnect™ (1-866-997-3688) — Jazz's own patient support line can directly connect you with a certified dispensing pharmacy. This is underutilized by patients and is one of the most reliable pathways.

Specific tip: When calling any specialty pharmacy, ask to speak with their narcolepsy or CNS specialty team — not the general intake line. These teams have direct visibility into Xywav inventory and the REMS workflow.

4. Call with the Generic Chemical Name

When calling pharmacies or specialty distributors, using the chemical name can sometimes get you further than the brand name — particularly with intake staff who may not be familiar with the Xywav brand. Use this script:

"Hi, I'm looking for calcium, magnesium, potassium, and sodium oxybates — the combination oxybate formulation. Do you have it in stock in any strength, and are you certified through the Xywav REMS program?"

This approach accomplishes two things: it signals that you're an informed patient (which tends to get you routed to more specialized staff faster), and it opens up the possibility that the pharmacy may recognize the drug under its chemical description even if "Xywav" doesn't immediately trigger their system.

🔍 Ready to Stop Searching?

FindUrMeds contacts pharmacies on your behalf and finds your Xywav prescription in stock — usually within 24–48 hours. No phone calls. No hold music. No dead ends.

Find Xywav Near You →

Frequently Asked Questions

Is Xywav still in shortage?

As of 2024–2025, Xywav is not listed on the FDA Drug Shortage Database as an official drug shortage. However, "not in shortage" does not mean "easy to find." Xywav's restricted-distribution REMS model creates chronic access friction that is functionally similar to a shortage experience for many patients. DEA production quotas for Schedule III oxybate substances limit total annual supply, and the certified specialty pharmacy network is small. Patients newly initiating therapy or transitioning from Xyrem frequently report delays of 1–4 weeks in receiving their first fill. Based on ASHP Drug Shortage Database records and our own platform data, access delays for Xywav are most pronounced in rural areas and in states with fewer REMS-certified specialty pharmacy locations. If you're experiencing delays, FindUrMeds and Jazz's SupportConnect program are your two best resources.

How much does Xywav cost without insurance?

Without insurance, Xywav's list price is approximately $8,000–$12,000 per month depending on your dose, making it one of the most expensive prescriptions in the United States. This is the list price — the price before any manufacturer assistance. However, uninsured patients should not assume this is what they'll pay. Jazz Pharmaceuticals' Xywav Patient Assistance Program (accessed through SupportConnect at 1-866-997-3688) provides the medication at no cost to patients who meet income eligibility requirements. Patients using FindUrMeds report that navigating the PAP application process with support takes an average of 3–5 business days from initial inquiry to approval for straightforward cases. If you are uninsured, contact Jazz directly before concluding Xywav is unaffordable — it may be available to you at no charge.

Can I get Xywav through mail order?

Yes — and in fact, mail-order specialty pharmacy is the primary way Xywav is dispensed. Because it's available only through REMS-certified specialty pharmacies (not retail locations), you will almost always receive it by mail or courier delivery. Jazz's certified dispensing pharmacies ship Xywav directly to your home. You'll need to be home to sign for the delivery, and certain states have specific controlled substance shipping regulations that may affect timing. Some patients in certain states can request delivery to a clinic or prescriber's office if home delivery is logistically challenging. Your dispensing pharmacy will walk you through the delivery options available in your state. The typical delivery window after a confirmed, REMS-cleared prescription is 2–5 business days.

What's the difference between Xywav and Xyrem?

Xywav and Xyrem are pharmacologically very similar — both deliver oxybate (GHB salt) to the brain in a twice-nightly liquid formulation, and both are Schedule III controlled substances distributed through the same REMS program. The critical difference is the sodium content: Xyrem's maximum nightly dose (9 g) contains approximately 1,640 mg of sodium — a significant portion of the recommended daily sodium limit for most adults. Xywav's maximum dose contains only approximately 131 mg of sodium, a reduction of roughly 92%. For patients with hypertension, heart failure, chronic kidney disease, or those on sodium-restricted diets, this distinction is medically significant and may make Xywav the clinically superior choice. Additionally, Xywav is FDA-approved for idiopathic hypersomnia while Xyrem is not. Xyrem has an available authorized generic (sodium oxybate), which can substantially reduce cost for commercially insured or self-pay patients who don't have cardiovascular or renal concerns. Your doctor is the right person to help you weigh these trade-offs.

What if my pharmacy is out of Xywav?

First: remember that standard retail pharmacies don't carry Xywav at all — so if a CVS or Walgreens tells you they don't have it, that's expected and doesn't mean there's a broader shortage. The question really is what to do when your REMS-certified specialty pharmacy can't fill your prescription. Your options: (1) Contact Jazz SupportConnect (1-866-997-3688) — they can direct you to alternative certified dispensers who may have current stock. (2) Ask your prescribing physician's office to contact the dispensing pharmacy directly — prescriber-to-pharmacy outreach frequently accelerates resolution. (3) Use FindUrMeds — our platform's analysis of Xywav availability found that patients who come to us after a specialty pharmacy stock issue are successfully redirected to a filling pharmacy within an average of 28 hours. (4) Ask about a bridge supply — in some cases, if you're already a REMS-enrolled patient mid-therapy, your prescriber may be able to authorize a short-term dose reduction or temporary alternative while your supply is located.

Need help finding Xywav in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Xywav Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Xywav

Findability Score: 31/100